QD Fluticasone-Vilanterol combo reduces COPD exacerbations October 04, 2016 By Anthony Vecchione In patients with COPD who have a history of exacerbations, a once-daily treatment regimen of combined fluticasone furoate and vilanterol was associated with fewer exacerbations than usual care without a greater risk of serious adverse events Is the U.S. making progress on a Zika vaccine? October 03, 2016 By Christine Blank Already, HHS has awarded around $433 million for Zika response and preparedness activities. In addition, the new Senate and House budget, passed in late September, contained $1.1 billion in Zika funding. Pharmacists’ role in administering vaccinations on the increase October 03, 2016 By Christine Blank The number of pharmacists providing vaccinations – both in the U.S. and around the world – is growing significantly. Risky antibiotic use threatens patients September 10, 2016 By Tracey Walker Patients are willing to use antibiotics without contacting a medical professional, according to a study published in Antimicrobial Agents and Chemotherapy. Oral Anticoagulant Safety, Apixaban, Statins and VTE According to a recent report from the Institute of Safe Medication practices (ISMP), FDA received 34,765 adverse drug event reports for oral anticoagulants in 2015. New dosage form for migraine treatment FDA approved Onzetra Xsail (Avanir Pharmaceuticals Inc.)— a fast-acting, low-dose sumatriptan dry powder formulation for the acute treatment of migraine with or without aura in adults. Pharmacists help to combat meningococcal disease September 09, 2016 By Christine Blank As bacterial meningitis spikes in certain regions of the U.S. and with more schools recommending vaccination, some pharmacy chains are helping to combat the disease. Study: Biosimilars as safe as branded drugs August 12, 2016 By Christine Blank New study finds that biosimilar medications for arthritis and other diseases areas safe and effective as their brand-name counterparts. Why pharmacists are concerned about the safety of biosimilars August 10, 2016 By Christine Blank Pharmacists and other healthcare professionals are looking to the FDA for more guidance on biosimilars and interchangeability with their reference products.